Finkelstein David Isaiah reported grant involving 4,117.8 derivative units of BELLRING BRANDS, INC. at $7.96 for $32.8k on Sep 30, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$32,777.69Shares × reported price
Shares traded
4,117.8BellRing Brands, Inc. Common Stock Equivalents
Price per share
$7.96Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
8,532.979Direct
Trade date
Sep 30, 2026Grant
Filed
Oct 2, 2026, 4:55 PM ET2-day reporting delay
Accession
0001628280-26-064615Code A · Transaction 235142
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

BRBR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BRBR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +45%1w ago +14%1d ago +4.3%
Returns since7d +15%30d +23%90d180d1y

Footnotes in full

F1: Reporting Person's retainer earned as a Director of Issuer is deferred into Issuer Common Stock equivalents under the Issuer's Deferred Compensation Plan for Directors. Reporting Person is credited with stock equivalents on a quarterly basis as soon as administratively practical following the quarter in which such retainer is earned. The value of these stock equivalents is distributed (on a one-for-one basis) in the form of Issuer Common Stock upon Reporting Person's retirement from the Board of Directors. F2: The Common Stock equivalents have no fixed exercisable or expiration dates.